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The burden of suffering for those with chronic leg ulceration
constitutes a major health care problem for patients, physicians,
and heath care systems. Quality of life is reduced for these individ-
uals, progress toward healing is frequently slow, recurrence rates
are high, and treatment is costly. Thus, this clinical problem
requires renewed research into pathophysiology and therapy.1
The pathophysiology of wound healing is complex and in-
volves at least four major factors: local tissue hypoxia, bacterial
colonization, repetitive ischemia-reperfusion injury, and altered
cellular and systemic stress responses in the aged patient.2 The
molecular biology of wound healing is increasingly complex and
involves inflammatory mediators, cellular elements, and a diverse
array of matrix synthesis, angiogenesis, and wound contraction.3
Vacuum-assisted wound closure (VAC) has been studied for
over 17 years, and many published reports have suggested its
superiority to conventional dressings.4 The occlusive dressing and
the vacuum pressure remove tissue fluid, which increases capillary
perfusion and wound oxygenation and decreases the content of
gram-negative rods such as pseudomonas while levels of staphylo-
coccus increase. Wounds develop granulation tissue more rapidly,
and the entire process to complete healing is accelerated.
This randomized study provides fresh research and strongly
advocates the use of VAC therapy in this mixed population of
ulcers. The preparation of the wound bed is faster, time to com-
plete healing with VAC therapy is a mean of 16 days shorter, and,
not surprisingly, the costs are less. Rapid improvement in quality of
life and pain are noted with VAC therapy, and this is critical for this
patient population, who are generally demoralized by their inabil-
ity to heal their wound.
Thus, VAC therapy alone is clearly beneficial for the healing of
chronic leg ulcers. This reinforces the many nonrandomized pub-
lications and this author’s anecdotal experience. However, this is
not the final chapter in chronic ulcer wound healing, as recurrences
rates were 52% with VAC therapy at 4 months. This rate and the
conventional therapy recurrence rate of 42% at 2 months are still
higher than everyone would like to see. The results of this study
demonstrate that further investigation and study are required to
refine the best algorithm and addition of other modalities to heal
these chronic ulcers permanently. In the meantime, this study
provides valuable level 1 evidence for VAC therapy at a lower cost
to the health system. This is good news for clinicians, administra-
tors, and, most importantly, patients.
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